Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Active and recent NIH-funded research on Complex Regional Pain Syndrome. Data from NIH RePORTER, last 36 months.
Complex Regional Pain Syndrome has emerging NIH research funding with 3 grants totaling $7.4M.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Complex Regional Pain Syndrome. Strongest funded area: Translational / Drug Development. Largest gap: Epidemiology / Natural History.
6 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for complex regional pain syndrome. Existing research activity suggests this may be a viable area for grant applications.
11 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for complex regional pain syndrome. Existing research activity suggests this may be a viable area for grant applications.
21 publications in Clinical Trial Publication but no NIH-funded grants found in Clinical Research for complex regional pain syndrome. Existing research activity suggests this may be a viable area for grant applications.
24 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for complex regional pain syndrome. Existing research activity suggests this may be a viable area for grant applications.
These grants mention Complex Regional Pain Syndrome as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.